Literature DB >> 10860686

Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival.

P Vanhems1, A Lepape, A Savey, P Jambou, J Fabry.   

Abstract

The objectives of this study were to identify the risk factors of nosocomial pulmonary infection (NPI) in intensive care units (ICUs) associated with antimicrobial-resistant bacteria (NPI-ARB) and to compare survival after NPI-ARB with NPI due to antimicrobial-sensitive bacteria (NPI-ASB). We analysed data from a surveillance network monitoring nosocomial infections in 27 mixed ICUs in the south-east of France. NPI surveillance data were recorded for 628 patients with documented NPI. The patients were stratified into 2 groups by type of pneumonia: NPI-ASB (445 patients) vs. NPI-ARB (183 patients). Variables associated with NPI-ARB were identified++ by multivariate logistic regression. Survival was calculated using the Kaplan-Meier method. A medical condition for ICU admission [odds ratio (OR) 1.98, 95% confidence interval (95% CI) 1.35-2.91], transfer from another hospital ward [OR 1.66, 95% CI (1.14-2.42)], a colonized central venous catheter [OR 3.47, 95% CI (1.46-8.21)], a stay of [eight days [OR 1.02, 95% CI (1.01-1. 05)] and mechanical ventilation [OR 2.10, 95% CI (1.31-3.36)] were independent risk factors of NPI-ARB. Median survival was 35 days after NPI-ARB and 32 days after NPI-ASB (P=0.92). Survival after bacterial NPI was not associated with antimicrobial susceptibility. Copyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2000        PMID: 10860686     DOI: 10.1053/jhin.2000.0752

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  13 in total

1.  Reduction of urinary tract infections acquired in an intensive care unit during a 10-year surveillance program.

Authors:  Philippe Vanhems; Dominique Baratin; Nicolas Voirin; Anne Savey; Emmanuelle Caillat-Vallet; Marie-Hélène Metzger; Alain Lepape
Journal:  Eur J Epidemiol       Date:  2008-07-10       Impact factor: 8.082

2.  Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.

Authors:  Caroline Landelle; Alain Lepape; Nicolas Voirin; Eve Tognet; Fabienne Venet; Julien Bohé; Philippe Vanhems; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

3.  Antibiotic susceptibility patterns of different bacteria isolated from patients with ventilator associated pneumonia (vap).

Authors:  Abdulrahman M Alqurashi
Journal:  J Family Community Med       Date:  2005-09

4.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

5.  Early-onset ventilator-associated pneumonia incidence in intensive care units: a surveillance-based study.

Authors:  Philippe Vanhems; Thomas Bénet; Nicolas Voirin; Jean-Marie Januel; Alain Lepape; Bernard Allaouchiche; Laurent Argaud; Dominique Chassard; Claude Guérin; Jean-Jacques Lehot; Marc-Olivier Robert; Gérard Fournier; Didier Jacques; François Artru; Pierre-Yves Gueugniaud; Dominique Chassard; Raphaëlle Girard; Jean-Charles Cêtre; Marie-Christine Nicolle; Marie-Hélène Metzger; Jacqueline Grando
Journal:  BMC Infect Dis       Date:  2011-09-06       Impact factor: 3.090

Review 6.  Economic impact of antimicrobial resistance.

Authors:  J E McGowan
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

7.  Evaluating mortality in intensive care units: contribution of competing risks analyses.

Authors:  Matthieu Resche-Rigon; Elie Azoulay; Sylvie Chevret
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

8.  Ventilator associated pneumonia and infection control.

Authors:  Emine Alp; Andreas Voss
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-04-06       Impact factor: 3.944

9.  Impact of surveillance of hospital-acquired infections on the incidence of ventilator-associated pneumonia in intensive care units: a quasi-experimental study.

Authors:  Thomas Bénet; Bernard Allaouchiche; Laurent Argaud; Philippe Vanhems
Journal:  Crit Care       Date:  2012-08-21       Impact factor: 9.097

10.  Costs and risk factors for ventilator-associated pneumonia in a Turkish university hospital's intensive care unit: a case-control study.

Authors:  Riza Hakan Erbay; Ata Nevzat Yalcin; Mehmet Zencir; Simay Serin; Habip Atalay
Journal:  BMC Pulm Med       Date:  2004-04-26       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.